Death is a Distant Rumor to the Young: The Bicuspid Aortic Valve. Hector I. Michelena, MD Assistant Professor of Medicine NO DISCLOSURES

Similar documents
Bicuspid Aortic Valve Hemodynamic Consequences

Bicuspid Aortic Valve: Only Valvular Disease? Artur Evangelista

The Bicuspid Aortic Valve: New Frontiers in Genetics and Interventions

BICUSPID AORTIC VALVE. Surgery everytime over 50 mm

Aortic Dissection in BAV Patients: The IRAD Experience and Beyond

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?

Impact of Obesity on the Risk of Aortic Dilatation in Patients with Bicuspid Aortic Valve

PREGNANCY AND CONGENITAL HEART DISEASE

New ASE Guidelines: What you must know

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results

PROPHYLACTIC AORTA SURGERY AT mm Which Risk Factors?

Operate NOT every BAV aorta at 5 cm. Markus Schwerzmann, MD

Surgical indications in ascending aorta aneurysms: What do we know? Jean-Luc MONIN, MD, PhD. Institut Mutualiste Montsouris, Paris, FRANCE

S. Bruce Greenberg, MD FNASCI and President, NASCI Professor of Radiology and Pediatrics University of Arkansas for Medical Sciences

Aortic regurgitation and aneurysm. epidemiology and guidelines

Sports Participation in Patients with Inherited Diseases of the Aorta

Ascending aorta dilation and aortic valve disease : mechanism and progression

Disclosures: Acute Aortic Syndrome. A. Michael Borkon, M.D. Director of CV Surgery Mid America Heart Institute Saint Luke s Hospital Kansas City, MO

The natural history of the bicuspid aortic valve and bicuspid aortopathy

Gender Differences in Valvular Heart Disease. Linda D. Gillam, MD FESC Disclosure: Core Lab services Edwards Lifesciences

What Are the Current Guidelines for Treating Thoracic Aortic Disease?

Dr.ssa Loredana Iannetta. Centro Cardiologico Monzino

SURGICAL INTERVENTION IN AORTOPATHIES ZOHAIR ALHALEES, MD RIYADH, SAUDI ARABIA

15500E. Sex Differences and Survival in Adults With Bicuspid Aortic Valves: Verification in 3 Contemporary Echocardiographic Cohorts

Aortic Regurgitation and Aortic Aneurysm - Epidemiology and Guidelines -

Diseases of the Aorta

Late results of aortic root repair & replacement. John Pepper Imperial College and Royal Brompton Hospital, London, UK.

SONOGRAPHER & NURSE LED VALVE CLINICS

Echocardiography Screening of Siblings of Children With Bicuspid Aortic Valve

Pregnancy, Heart Disease and Imaging. Hemodynamics. Decreased systemic vascular resistance. Physiology anemia

What Determines Aortic False Lumen Growth Post Dissection?

The Ross Procedure: Outcomes at 20 Years

Echocardiography in Adult Congenital Heart Disease

2 nd AVRS 2016: Nimesh D. Desai, M.D., Ph.D. Co Director, Aortic and Vascular Center for Excellence University of Pennsylvania

THE AORTA IN TURNER SYNDROME. Dr. L. Demulier Annual meeting of the BWGACHD March 11 th 2016

HTAD PATIENT PATHWAY

Prosthesis-Patient Mismatch or Prosthetic Valve Stenosis?

Another pregnancy after a previous aortic dissection in pregnancy?

Richard L. Hallett, MD

Quality Outcomes Mitral Valve Repair

Emergency Intraoperative Echocardiography

Asymptomatic Valvular Disease:

Valvular Heart Disease

Stability of Ascending Aortic Dilatation Following Aortic Valve Replacement

Chronic Primary Mitral Regurgitation

The Bicuspid AV Surgical Considerations

Modeling of predissection aortic size in acute type A dissection: More than 90% fail to meet the guidelines for elective ascending replacement

Long-Term Outcome of Patients With Aortic Regurgitation: Medical Management and Surgical Indications

The Role Of Decellularized Valve Prostheses In The Young Patient

Echocardiographic Evaluation of the Aorta

The Dilated Pulmonary Artery: Is there a risk of Dissection?

Aneurysms & a Brief Discussion on Embolism

Transcatheter Therapy for Coarctation of the Aorta: The Results of Our Efforts

Valvular Heart Disease. Dr. HANAN ALBACKR

Decellularization of Aortic Homografts: South American and European Current Experience

Multi-imaging modality approach. Covadonga Fernández-Golfín Cardiac Imaging Unit. Cardiology Department. Ramón y Cajal Hospital.

Maternal Cardiac Disease In Pregnancy. August 25, 2017 PREGNANCY ECHO CONFERENCE

Quantitation of Aortic Regurgitation ASCeXAM / ReASCE Review Course

TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH

Aortic valve repair: When and how to employ this novel approach?

Transcatheter aortic valve implantation and pre-procedural risk assesment

Yuki Nakamura, Masahiro Ryugo, Fumiaki Shikata, Masahiro Okura, Toru Okamura, Takumi Yasugi and Hironori Izutani *

CMR for Congenital Heart Disease

Managing the aortic root in pregnancy

Critical Care in Obstetrics: An Innovative and Integrated Model for Learning the Essentials

Aortic Valve Repair a Modular and Geometric Approach. H.-J. Schäfers Dept. of Thoracic and Cardiovascular Surgery University Hospital of Saarland

Aortic Coarctation Imaging and Management in Adults. Michael D. Hope, MD

Bicuspid aortic valve disease

The Changing Epidemiology of Valvular Heart Disease: Implications for Interventional Treatment Alternatives. Martin B. Leon, MD

Giant Thoracic Aneurysm Following Valve Replacement for Bicuspid Aortic Valve

TSDA Boot Camp September 13-16, Introduction to Aortic Valve Surgery. George L. Hicks, Jr., MD

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington

The Bicuspid AV Surgical Conisiderations

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Detailed Order Request Checklists for Cardiology

Unusual Causes of Aortic Regurgitation. Case 1

Imaging Cardiovascular Disease in Pregnancy

Case 1. Aortic Disasters. Case 2. Case 3. Diagnosis, Imaging Techniques and Management

Aortic stenosis (AS) is common with the aging population.

CARDIAC PHYSIOLOGIST LED AORTIC STENOSIS SURVEILLANCE CLINIC

Early and One-year Outcomes of Aortic Root Surgery in Marfan Syndrome Patients

Echocardiographic Cardiovascular Risk Stratification: Beyond Ejection Fraction

Surgical Thresholds for proximal aortic disease- Search for an aortic fingerprint to track a Silent Killer

Prosthetic valve dysfunction: stenosis or regurgitation

Adult Cardiac Surgery

Uptofate Study Summary

Long-term results of a strategy of aortic valve repair in the paediatric population: Should we avoid cusp extension?

Multimodality Imaging in Aortic Diseases:

Acute Valve Regurgitation Catherine M. Otto, MD J. Ward Kennedy-Hamilton Endowed Chair in Cardiology University of Washington, Seattle

Acute Aortic Syndromes

Adult Echocardiography Examination Content Outline

Pregnancy in Marfan Syndrome and Bicuspid Aortic Valve Related Aortopathy

The role of false lumen intervention to promote remodelling via induced thrombosis the FLIRT concept

From Valve to Arch: How s Your Aorta? March 7, 2011

When Should I Order a Stress Test or an Echocardiogram

Remodeling of the Remnant Aorta after Acute Type A Aortic Dissection Surgery

Focused. se with 2008 F. lar Heart Diseas. date. ents With Valvul. Upd. gement of Patie. lines for Manag. HA 2006 Guidel ACC/AH. Fig.

42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim

Reconstruction of the Aortic Valve and Root A Practical approach Why and when to repair the aortic valve. Diana Aicher. September 16 th - 18 th 2015

Five-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe Aortic Stenosis: The PARTNER Trial

Transcription:

Death is a Distant Rumor to the Young: The Bicuspid Aortic Valve Hector I. Michelena, MD Assistant Professor of Medicine NO DISCLOSURES

Leonardo s notes Royal collection, Queen Elizabeth II

Leonardo s notes Royal collection, Queen Elizabeth II

After Leonardo s description 1844 Paget peculiar liability of BAV to disease pathologic curiosity 1858 Peacock BAV become thick ossified inducing obstruction and incompetency 1886 Osler BAV develop infective endocarditis 1927 Abbott BAV and aortic dissection

Circulation, 1978

Mayo Clinic Ao dissection 9 times more common in BAV than TAV

The facts MRI 20 patients with nonstenotic BAVs and 20 matched control patients Reduced aortic elasticity J Am Coll Cardiol 2007;49:1660

The facts Marfan-like BAV is associated with accelerated degeneration of the aortic media matrix disruption and smooth muscle cell loss MMP activity may be elevated in the aorta of patients with BAV Circulation 2002;106;900

Fact: BAV= dilatation of the aorta HEART 2006;92:1496 Ascending aorta Z score 0.4 year Mean age 35 years

Possibly the majority of patients with bicuspid aortic valve will develop serious complications The bicuspid valve may be responsible for more deaths and morbidity than the combined effects of all the other congenital heart defects

Questions What is the true incidence of aortic dissection in BAV? What is the true incidence of aortic bacterial endocarditis in BAV? Is BAV disease a life-threatening condition?

Olmsted County Retrospective-cohort study Geographically-defined population, all echos accounted for All patients with echo-bav included, long follow-up High echocardiography utilization Aorta outcomes ascertained: Medical records(surgical-medical), mailed surveys, telephone calls Deaths: Death certificates, autopsy reports, coroner s cases

Complications of the Aorta in Bicuspid Aortic Valve Disease: A 25 Year Follow-up Population Study Michelena, Khanna, Mahoney, Margaryan, Topilsky, Suri, Sundt, Enriquez-Sarano Residents of Olmsted County (Minn), all ages Echo diagnosed and confirmed BAV, 1980 to 1999 January 1980 to December 1999 322,230 echocardiograms Mayo Clinic, Rochester 41,687 (13%) Olmsted County 489 BAVs (1% of Olmsted County echocardiograms, 0.3% of the Olmsted County population for 2000) Total 416, 69% male, 35 21 years, 79% 18 y 84% typical BAV, FU 16 7 years (range 0.002 to 29 years). (until 2008-2009, death or 20 y) in 95% Survival, BE, AA, AD, ASx,

Baseline characteristics by total aorta events Variable Total N= 416 Aorta events Yes N= 84 Aorta events No N= 332 P value Age years 35±21 37 ± 21 35 ± 21 0.44 Males n (%) 289 (69) 66 (79) 220 (69) 0.035 HTN n (%) 93 (22) 26 (31) 67 (20) 0.04 Smoking n 132 (32) 29 (35) 103 (31) 0.6 (%)* Diabetes n (%) 15 (4) 2 (0.2) 13 (4) 0.5 Coarctationn 30 (7) 12 (14) 18 (5) (%) 0.009 Other 54 (13) 15 (18) 39 (12) congenital heart 0.15 disease n (%) EF % 62 ± 7 62 ± 7 63 ± 7 0.24 Root / ascending aorta diametermm Typical BAV n (%) Aortic regurgitation n (%)** Complete FUn (%) BAV diagnosis 1980-1989 34 ± 8 39 ± 11 33 ± 7 <0.0001 350 (84) 73 (87) 277 (83) 0.5 246 (62) 49 (67) 197 (62) 0.8 393 (95) 82 (98) 311 (94) 0.2 152 (37) 39 (46) 113 (34) 0.04

BAV type There was no relation between BAV phenotype and aortic size, sex, aortic complications, AVR, stenosis or regurgitation

Survival 92 1 % and 80 3 % at 10 and 25 years after BAV diagnosis Compare survival matched for age and sex

P=0.98

Bacterial endocarditis 100 80 60 % 40 20 0 2 ± 0.5 % 0 5 10 15 20 25 Time -Yr 5 ± 2% BE 11 patients (2 died, 9 required AVR) BE 1.4% of typical and 8% of atypical BAVs (p=0.003)

Aortic Dissections Variable Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Sex male female male male male Age BAV echo 47 N/A 56 39 70 diagnosis - years Age at AD - years 47 82 61 52 73 Type dissection Ascendi ng Aortic diameter at baseline - mm Time between AVR and dissection Aortic Coarctation Acute ascending Acute ascending 70 Not measured Acute ascending Acute ascending 47 46 46 N/A 9 years 13 months 3 days N/A no no no no no Acute Descending Hypertension yes no yes?? yes Smoking yes no no no no BAV type typical typical typical typical typical BAV dysfunction at baseline echo Severe aortic regurgitation Severe aor tic stenosis Moderate aortic stenosis Moderate aortic regurgitation Moderate aortic stenosis

Sudden Cardiac Deaths Variable Patient 1 Patient 2 Patient 3 Patient 4 Pat ient 5 Se Age x BAV echo diagnosi - years sage at year death Autops s Cause y of death by death certificat e ascending aorta dimension - f e6 8 7 7 mal e n Cardiopulmonary o arrest 3 2 mal 7e 0 8 2 n Cardiopulmonary o arrest mal 3e 9 5 2 54 3 7 n Witnessed o ventricular fib illatio Suspected r n M I mal 6e 4 6 4 ye Suspected s Arrhythmic death, no aortic dissectio 7 n 0 f e6 2 7 3 mal e n Cardiopulm o nary arrest, o suspected MI 4 4 AVR / AAR Yes / Comorbiditie CAD, no s HTN No / HTN, no CAD, CH F Yes / HTN, nocad, CH F No / o No / S/P n MVR, HTN, no CAD, CH CH F F

Risk of Aorta Surgery Relative to Aortic Valve Replacement 60 50 40 AVR Total Ao Sx AA Sx Ao coar Sx 52 ± 4% Events % 30 20 26 ± 4% 23 ± 4% 10 0 0 5 10 15 20 25 Time years 3 ± 1%

Risk of Aortic Aneurysm and Aortic Dissection 40 40 ± 5% 30 AA AD Events % 20 10 0 0 5 10 15 20 25 Time years 1 ± 0.5%

Predictors of ALL aortic events Univariate Hazards Ratio Confidence interval P value Age > 50 years 4.3 2.4-7.7 <0.0001 Root or asc Ao > 40 mm baseline 8.1 4.5-15 <0.0001 Male sex 1.9 1.1-3.6 0.02 HTN 2.7 1.5-4.5 0.0008 AR at baseline 2.2 1.3-3.9 0.03 Multi variate Age > 50 years Root or asc Ao > 40 mm baseline 3.5 1.4-8.6 0.005 7.2 3.2-16.9 <0.0001

Conclusions The largest, population-based, longest follow-up of BAV up to date Survival no different than general population Ao valve dysfunction common, AVR > 50% at 25 years Endocarditis is uncommon, risk 5% at 25 years, but highly morbid Aortic aneurysm is common, risk 40% at 25 years Aortic dissection is rare, risk 1% at 25 years Age (4x) and aorta diameter (7x) at baseline are independent predictors of aorta events Echo surveillance in >50 yo and >40mm

Speculative conclusions Aortic dissection possibly more common in men, dilated aortas, dysfunctional BAV with interval AVR By operating AA, we are saving dissections? Answer = genetics?

Limitations Retrospective 80% >18 year-old---not pediatric True Incidence of Aneurysms could be underestimated since 20% did not have follow-up echocardiogram